NPI registry status
Active
2026 NPPES data Interventional Pain Medicine Physician NPI 1609371145 M.D
Verify on CMS → Mark Cohen, M.D
Interventional Pain Medicine Physician in Brooklyn, New York.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 1,603 in Interventional Pain Medicine Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
528
Medicare Part D claims · 162 beneficiaries · Interventional Pain Medicine Physician avg: 2K
Generic prescribing
89%
generic claims · 11% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$1.3K
48 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2024
What the federal data shows
Mark Cohen, M.D filed 528 Medicare Part D claims in 2024 as an Interventional Pain Medicine Physician in Brooklyn, New York, prescribing 89% generic.
- 528
- Part D claims, 2024
- 89%
- generic prescribing
- Likely
- board-certified (heuristic)
- ≥65th
- pct by Part D claim volume (lower-bound band)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Mark Cohen, M.D
Federal records show an active NPI with Medicare Part D prescribing activity — verifiable registry data, not a proprietary rating.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1609371145), first enumerated 03/27/2018.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 528 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
Board certification signal
Heuristic suggests board-certified status based on ABMS-eligible specialty taxonomy plus active CMS participation signals — not a direct ABMS verification.
- Reported
Hospital affiliations
1 CMS Care Compare hospital affiliation on record — practice footprint from the Doctors and Clinicians file.
Source: CMS Care Compare
- Reported
Industry payment transparency
$1.3K in reported industry payments (48 transfers) in 2024 under the federal Sunshine Act — disclosed transfers of value, not a quality rating.
Source: CMS Open Payments
- State context
State board disciplinary context
New York statewide board action statistics are published annually — these figures describe aggregate state activity, not Mark Cohen, M.D's individual license status. Verify directly with the state medical board.
Source: NYSBPMC annual report 2023
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1609371145 · Interventional Pain Medicine Physician
NPI-10 · ENUM-RECENT · TAX-NARROW · RX-LIGHT · BOOK-THIN · PHOTO-ENUM
- NPI-10 1609371145
- ENUM-RECENT 2018
- TAX-NARROW 1,603
- RX-LIGHT 528
- BOOK-THIN 100 in New York
- PHOTO-ENUM Madelyn Craig · 2018
Mark Cohen, M.D's Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2024, across all CMS prescribers nationally
528 ≥ 65th percentile 65% of 1,416,883 prescribers are in lower value bands
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative 100-claim band: it counts only prescribers in lower claim-volume bands. Medicare Part D claim volume is activity context, not a quality measure or recommendation. See methodology § corpus placement.
Source CMS Medicare Part D Prescriber Public Use File · 2024
✓
Board certification likely (heuristic, not verified)
Mark Cohen, M.D practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Mark Cohen, M.D?
Quality data not reportedPrimary specialty
Interventional Pain Medicine Physician
Medicare Part D claims
528 76% vs specialty avg
Specialty distribution in New York
How Interventional Pain Medicine Physician compares to other specialties among New York providers
Board certification
Not published by CMS
CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Interventional Pain Medicine Physician. Verify directly:
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1609371145 |
|---|---|
| Specialty | Interventional Pain Medicine Physician |
| Credentials | M.D |
| Gender | Male |
| NPI Issued | 03/27/2018 |
Hospital and facility affiliations
Facilities where Mark Cohen, M.D bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
LR Medical PLLC
Brooklyn, NY
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Mark Cohen, M.D. Source: openpaymentsdata.cms.gov.
Total received
$1.3K
Largest payer
Galderma Laboratories, L.P.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context - New York NYSBPMC 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~100K New York medical licensees in 2023 - they are NOT specific to Mark Cohen, M.D. To verify Mark Cohen, M.D's current license status, search the NYSBPMC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
312
Total board actions, New York 2023
Across 302 cases
3.12
Actions per 1,000 licensees
New York statewide rate
probation
Most common action type
89 cases
NYSBPMC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the New York disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Typical
Mark Cohen, M.D - brand share 11.0%
Interventional Pain Medicine Physician average
11% brand-name claims vs 89% generic, on 528 2024 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
528
Total Claims
$81K
Total Drug Cost
162
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 551.433
- Total Day Supply
- 15,257
- Brand vs Generic
- 11% brand / 89% generic
- Brand Drug Cost
- $65K
- Generic Drug Cost
- $15K
- Opioid Claims
- 129 (24.4% rate)
Patient Demographics
- Average Patient Age
- 65.4 years
- Avg HCC Risk Score
- 1.45
- Gender Split
- 57% female / 43% male
- Age Distribution
- <65: 72, 65-74: 61, 75-84: N/A, 85+: N/A
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.
What Mark Cohen, M.D prescribes most
Top Medicare Part D drugs by claim count, 2024
- Gabapentin
Gabapentin
79 claims
- Oxycodone-Acetamin…
Oxycodone-Acetaminophen
55 claims
- Celecoxib
Celecoxib
33 claims
- Pregabalin 31
Pregabalin
31 claims
- Tizanidine Hcl 28
Tizanidine Hcl
28 claims
- Baclofen 26
Baclofen
26 claims
- Diclofenac Sodium 22
Diclofenac Sodium
22 claims
- Oxycodone Hcl 18
Oxycodone Hcl
18 claims
| Drug | Claims |
|---|---|
| Gabapentin | 79 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 55 |
| Celecoxib | 33 |
| Pregabalin | 31 |
| Tizanidine Hcl | 28 |
| Baclofen | 26 |
| Diclofenac Sodium | 22 |
| Oxycodone Hcl | 18 |
| Qulipta Atogepant | 17 |
| Tramadol Hcl | 17 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
More Interventional Pain Medicine Physician in NY →
All providers in New York →
Compare specialties →
Interventional Pain Medicine Physician Overview
How Mark Cohen, M.D fits within the Interventional Pain Medicine Physician landscape nationally.
1,603
Interventional Pain Medicine Physician Providers in US
53
States with Interventional Pain Medicine Physician
2,221
Avg Claims per Provider
Mark Cohen, M.D's 528 claims are below the specialty average of 2,221.
Nationwide Interventional Pain Medicine Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Cohen, both outside New York so the neighborhoods are not geographic containment.
Same NPPES enumeration year (2018)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Interventional Pain Medicine Physician Providers in New York
Other clinicians with the same primary specialty enrolled in New York, drawn from the same CMS NPPES roster as Cohen.
One of 100 Interventional Pain Medicine Physician providers enrolled in New York, 5 are shown here.
Dr. Boris Abayev
M.D.
Rego Park, NY
Dr. Arun Agrawal
M.D.
Hempstead, NY
Dr. Uel Alexis
M.D.
Staten Island, NY
Dr. Kathy Aligene
M.D.
Long Island City, NY
Dr. Julia Altmann
M.D.
New York, NY
Compare Interventional Pain Medicine Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Mark Cohen, M.D's specialty? ▼
Mark Cohen, M.D specializes in Interventional Pain Medicine Physician and practices in Brooklyn, New York. Credentials: M.D.
How much does Mark Cohen, M.D prescribe under Medicare Part D? ▼
In 2024, Mark Cohen, M.D wrote 528 Medicare Part D claims totaling $81K in drug costs for 162 beneficiaries.
Where is Mark Cohen, M.D located? ▼
Mark Cohen, M.D is located at 2279 CONEY ISLAND AVE, Brooklyn, NY, 11223. Phone: (718) 998-9890.
What is Mark Cohen, M.D's NPI number? ▼
Mark Cohen, M.D's National Provider Identifier (NPI) is 1609371145, issued on 03/27/2018.
Does Mark Cohen, M.D prescribe more brand-name or generic drugs? ▼
Mark Cohen, M.D's prescribing is 11% brand-name and 89% generic drugs by claim count, with $65K in brand drug costs.
Does Mark Cohen, M.D prescribe opioids? ▼
Yes, Mark Cohen, M.D had 129 opioid claims in 2024 with an opioid prescribing rate of 24.4%.
How many Interventional Pain Medicine Physician providers are there in the US? ▼
There are 1,603 Interventional Pain Medicine Physician providers across 53 states in the US. The average Interventional Pain Medicine Physician provider writes 2,221 Medicare Part D claims per year.
What drugs does Mark Cohen, M.D prescribe most often? ▼
Based on 2024 Medicare Part D data, Mark Cohen, M.D's most frequently prescribed drugs include Gabapentin, Oxycodone-Acetaminophen, Celecoxib. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Mark Cohen, M.D accept Medicare? ▼
Mark Cohen, M.D appears in CMS Medicare data with 528 Part D claims and 162 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Mark Cohen, M.D's credentials? ▼
Mark Cohen, M.D's NPI is 1609371145 with credentials M.D. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.